Cingulate Reaffirmed Buy
H.C. Wainwright reaffirms buy rating on Cingulate ahead of FDA decision, citing potential upside.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.